Emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease.
作者信息
Kapoor Shailendra
机构信息
Richmond, VA, USA.
出版信息
Biologics. 2012;6:135-6. doi: 10.2147/BTT.S31959. Epub 2012 Jun 6.
Abstract
摘要
相似文献
1
Emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease.帕利夫明新出现的临床应用：超越其在口腔黏膜炎和移植物抗宿主病中的应用。
Biologics. 2012;6:135-6. doi: 10.2147/BTT.S31959. Epub 2012 Jun 6.
2
Palifermin: new drug. Prevention of oral mucositis: inappropriate evaluation.帕利夫明：新药。口腔黏膜炎的预防：评估不当。
Prescrire Int. 2007 Aug;16(90):135-8.
3
Palifermin for oral mucositis after intensive therapy for hematologic cancers.帕利夫明用于血液系统恶性肿瘤强化治疗后的口腔黏膜炎
N Engl J Med. 2004 Dec 16;351(25):2590-8. doi: 10.1056/NEJMoa040125.
4
Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis.帕利夫明（角质形成细胞生长因子-1）改善口腔黏膜炎的疗效。
Core Evid. 2010 Jun 15;4:199-205. doi: 10.2147/ce.s5995.
5
Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support.帕利夫明（凯纷）用于治疗需要造血干细胞支持的血液系统恶性肿瘤患者的口腔黏膜炎。
J Oncol Pharm Pract. 2005 Sep;11(3):121-5. doi: 10.1191/1078155205jp159oa.
6
Impact of palifermin on incidence of oral mucositis and healthcare utilization in children undergoing autologous hematopoietic stem cell transplantation for malignant diseases.帕利夫明对接受恶性疾病自体造血干细胞移植的儿童口腔黏膜炎发生率及医疗资源利用的影响。
Pediatr Transplant. 2014 Mar;18(2):211-6. doi: 10.1111/petr.12192. Epub 2013 Nov 28.
7
Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.单次剂量培非格司亭预防癌症患者多周期化疗期间重度口腔黏膜炎：一项随机试验。
Ann Intern Med. 2010 Sep 21;153(6):358-67. doi: 10.7326/0003-4819-153-6-201009210-00003.
8
Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis.使用帕利夫明预防大剂量甲氨蝶呤引起的口腔黏膜炎。
Ann Oncol. 2008 Sep;19(9):1644-9. doi: 10.1093/annonc/mdn179. Epub 2008 May 2.
9
The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant.帕利夫明（凯纷）对接受造血干细胞移植的血液病患者口腔黏膜炎及急性移植物抗宿主病的影响。
Bone Marrow Transplant. 2007 Nov;40(10):983-8. doi: 10.1038/sj.bmt.1705846. Epub 2007 Sep 10.
本文引用的文献
1
Randomized phase II study of palifermin for reducing dysphagia in patients receiving concurrent chemoradiotherapy for locally advanced unresectable non-small cell lung cancer.随机 II 期研究帕利夫林在接受局部晚期不可切除非小细胞肺癌同期放化疗的患者中减少吞咽困难的作用。
J Thorac Oncol. 2012 Jan;7(1):157-64. doi: 10.1097/JTO.0b013e31822f6526.
2
Keratinocyte growth factor gene therapy ameliorates ulcerative colitis in rats.角质细胞生长因子基因治疗改善大鼠溃疡性结肠炎。
World J Gastroenterol. 2011 Jun 7;17(21):2632-40. doi: 10.3748/wjg.v17.i21.2632.
3
Palifermin for management of treatment-induced oral mucositis in cancer patients.帕利夫明用于治疗癌症患者的治疗引起的口腔黏膜炎。
Biologics. 2009;3:111-6. doi: 10.2147/btt.2009.2871. Epub 2009 Jul 13.
4
Effect of recombinant human keratinocyte growth factor (rHuKGF, Palifermin) on radiation-induced mouse urinary bladder dysfunction.重组人角质形成细胞生长因子（rHuKGF，帕利夫明）对辐射诱导的小鼠膀胱功能障碍的影响。
Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):528-33. doi: 10.1016/j.ijrobp.2007.05.074.
5
Treatment of severe hemorrhagic cystitis after allogeneic stem cell transplantation with palifermin, a recombinant human keratinocyte growth factor.
Biol Blood Marrow Transplant. 2007 Jul;13(7):872-4. doi: 10.1016/j.bbmt.2007.04.002. Epub 2007 May 23.
6
Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA rats.帕利夫明可减轻荷瘤DA大鼠接受伊立替康治疗后的腹泻并提高生存率。
Int J Cancer. 2005 Sep 1;116(3):464-70. doi: 10.1002/ijc.21082.
Zotero 插件